Merkoša sitáhtat
APA-čujuhus (7. p.)
Oviedo-Joekes, E., Strang, J., Lintzeris, N., Treloar, C., Rodgers, C., Ezard, N., . . . Brink, W. v. d. (2024). Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: A protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost. BMJ Publishing Group.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Chicago-čujuhus (17. p.)
Oviedo-Joekes, Eugenia, et al. Implementation of Time-limited Parenteral Hydromorphone in People with Treatment-resistant Injecting Opioid Use Disorder: A Protocol for a Single-site, Uncontrolled, Open-label Study to Assess Feasibility, Safety and Cost. BMJ Publishing Group, 2024.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
MLA-čujuhus (9. p.)
Oviedo-Joekes, Eugenia, et al. Implementation of Time-limited Parenteral Hydromorphone in People with Treatment-resistant Injecting Opioid Use Disorder: A Protocol for a Single-site, Uncontrolled, Open-label Study to Assess Feasibility, Safety and Cost. BMJ Publishing Group, 2024.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.